Problems, interventions and complications in long-term oral anticoagulation therapy
- PMID: 12652152
- DOI: 10.1023/a:1022070406307
Problems, interventions and complications in long-term oral anticoagulation therapy
Abstract
Background: If problems, interventions and complications occurring during oral anticoagulation (OAC) are related with age, indication for OAC, hypertension, diabetes, previous stroke, and number of additional drugs.
Material and methods: Clinical characteristics, additional drugs, problems, interventions and complications of outpatients whose OAC was controlled between two years were registered. Potential gastrointestinal and urologic bleeding sources were eliminated prior to initiation of OAC. Five-hundred-seventy-nine patients (mean age 65 years, 44% female) were observed for 590 patient-years.
Results: Medical problems occurred in 352/100 patient-years (% p-y), organisational problems in 276% p-y, interventions in 636% p-y and complications in 13.8% p-y. Patients >65 years had less organisational problems (254 vs. 302% p-y, p = 0.0092) and interventions (574 vs. 713% p-y, p = 0.0003) than patients < or =65 years. The 35 patients with heart valve prosthesis had more life-threatening and fatal complications (12% p-y) than the 360 patients with atrial fibrillation (1.0% p-y), 128 patients with venous thromboembolism or 56 patients with other indications (0.0% p-y, p = 0.0024). Problems, interventions and complications were not related with hypertension (n = 297), diabetes (n = 97) or previous stroke (n = 90). Patients with >3 additional drugs/day had a higher complication rate than patients with < or =3 drugs/day (21 vs. 8.7% p-y, p = 0.0238). Patients with complications had more headache (27 vs. 20% p-y, p = 0.0036), chest pain (45 vs. 27% p-y, p = 0.0150), abdominal pain (25 vs. 15% p-y, p = 0.0350) and pain in the limbs (55 vs. 42% p-y, p = 0.0044) than patients without complications.
Conclusions: By careful monitoring, eliminating potential bleeding sources, treating pain adequately and minimizing additional drugs the complications of OAC can be kept low.
Similar articles
-
Evaluation of risk factors for stroke/embolism and of complications due to anticoagulant therapy in atrial fibrillation.Stroke. 2001 Oct;32(10):2246-52. doi: 10.1161/hs1001.097090. Stroke. 2001. PMID: 11588308 Clinical Trial.
-
Primary and secondary stroke prevention in nonrheumatic atrial fibrillation by oral anticoagulation.Eur Neurol. 2003;50(3):127-35. doi: 10.1159/000073052. Eur Neurol. 2003. PMID: 14530617 Review.
-
Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.Acta Cardiol. 2019 Apr;74(2):131-139. doi: 10.1080/00015385.2018.1475029. Epub 2018 Jun 4. Acta Cardiol. 2019. PMID: 29863432
-
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].G Ital Cardiol. 1997 Mar;27(3):231-43. G Ital Cardiol. 1997. PMID: 9244725 Clinical Trial. Italian.
-
[Use of oral anticoagulants in outpatient setting].Pol Merkur Lekarski. 2008 May;24(143):463-7. Pol Merkur Lekarski. 2008. PMID: 18634397 Review. Polish.
Cited by
-
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.J Thromb Thrombolysis. 2011 Nov;32(4):417-25. doi: 10.1007/s11239-011-0621-6. J Thromb Thrombolysis. 2011. PMID: 21773837
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical